Дисертації з теми "Vaccines"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 дисертацій для дослідження на тему "Vaccines".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.
Farfan, Arribas Diego Jose. "DNA Vaccines Against HIV-1: Augmenting Immunogenicity of gp120." Link to electronic thesis, 2002. http://www.wpi.edu/Pubs/ETD/Available/etd-0107102-160706/.
Повний текст джерелаParker, Christopher S. "Effect of a codon optimized DNA prime on induction of anti-influenza protective antibodies." Worcester, Mass. : Worcester Polytechnic Institute, 2007. http://www.wpi.edu/Pubs/ETD/Available/etd-040907-100839/.
Повний текст джерелаSatti, Iman. "Immunogenicity of anti-leishmaniasis vaccines in man /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-779-7/.
Повний текст джерелаRainczuk, Adam 1976. "Evaluation of DNA vaccine targeting strategies and expression library immunisation against lethal erythrocytic stage Malaria." Monash University, Dept. of Biochemistry and Molecular Biology, 2003. http://arrow.monash.edu.au/hdl/1959.1/5685.
Повний текст джерелаGrubb, Kimberley L. "A genomic approach to the identification of novel malaria vaccine antigens /." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=98715.
Повний текст джерелаAtcheson, Erwan. "Prospects for enhancing malaria vaccine efficacy by combining pre-erythrocytic antigens." Thesis, University of Oxford, 2017. http://ora.ox.ac.uk/objects/uuid:6506c003-7065-4d48-b049-f5e9136443d5.
Повний текст джерелаHutchings, Claire L. "Combination vaccines." Thesis, University of Oxford, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437038.
Повний текст джерелаSingh, Gagandeep. "RNA Viral Prophylaxis: Problems and Potential Solutions." Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/29458.
Повний текст джерелаUnited States Department of Agriculture, National Institute of Food and Agriculture (USDA-NIFA)
North Dakota State Agricultural Products Utilization Committee (ND APUC)
North Dakota State Board of Agricultural Research (ND SABRE)
Khan, Tila. "Tailored influenza virus vaccines for both the young and old: Vaccine Efficacy of Whole Inactivated Vaccines bearing Immunomodulatory Adjuvants or Multimeric peptides." Diss., Virginia Tech, 2012. http://hdl.handle.net/10919/77130.
Повний текст джерелаPh. D.
Dannetun, Eva. "Reasons for non-vaccination /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-739-1/.
Повний текст джерелаZhang, Yaobi. "Schistosoma japonicum : studies on defined antigen vaccines and irradiated vaccines." Thesis, London School of Hygiene and Tropical Medicine (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285204.
Повний текст джерелаDunachie, Susanna Jane. "Malaria vaccines and microarrays : clinical and laboratory evaluation of two vaccine regimens." Thesis, Open University, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.446277.
Повний текст джерелаBernocchi, Beatrice. "Porous maltodextrin nanoparticles for the intranasal delivery of vaccines." Thesis, Lille 2, 2016. http://www.theses.fr/2016LIL2S010/document.
Повний текст джерелаNanoparticles technology for mucosal delivery of vaccines received a growing interest in the last decades. Intranasal administration owns great advantages for immune system stimulation, such as local and systemic protection against infectious diseases. However delivery systems and adjuvants are often required to efficiently trigger mucosal and systemic immune responses. In this thesis, nanoparticles (NP) have been evaluated as delivery system for a nasal universal influenza vaccine in a People Program of the European Union Seventh Framework Program FP7 called UniVacFlu. The aim of the UniVacFlu network is to develop a universal influenza vaccine administered through the mucosal route. We used porous maltodextrin nanoparticles with a lipidic core (NPL). We loaded an adjuvanted antigen named CTA1-3M2e-DD in the NPL. CTA1-3M2e-DD is composed of the A1 subunit of the cholera toxin and a conserved epitope of influenza A virus (M2e), while DD, dimer of the synthetic analogue of the Staphyloccous aureus protein A, targets B cells. Interestingly the antigen loading in NPL was quantitative for the antigen: NPL 1:5 mass ratio and the formulation was stable for at least six months at 4°C. We assessed the successful delivery of the antigen by NPL in airway epithelial cells and macrophages. These formulations are currently evaluated by the UniVacFlu consortium in mice.One of the main issues of intranasal vaccines is the toxicity that can be elicited by the nose-brain passage of one of their components. We investigated the loading of antigens in NPL and their delivery in airway mucosa. We observed a high endocytosis of NPL and an increased protein delivery into the cells. On a transwell model of the airway mucosa we assessed the absence of transcytosis and paracellular passage of the NPL. In vivo results confirmed the lack of nose-brain passage of the NPL, as NPL were found not to cross the mucosa. Interestingly, we observed an increased nasal residence time of the protein targeted by NPL. The particles after having delivered their payload are totally eliminated through the gastrointestinal tract, making these nanoparticles good candidates for mucosal delivery system. These results highlight the interest of NPL as vectors for mucosal delivery of drugs
Busch, Marc Gregory. "Evaluation of different SIV plasmid DNA vaccines : a model for HIV vaccine development /." For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2004. http://uclibs.org/PID/11984.
Повний текст джерелаFredslund, Andersen Rikke. "Developing recombinant poxvirus vaccines." Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433236.
Повний текст джерелаKohli, Ashish Kumar. "Transcutaneous delivery of vaccines." Thesis, University College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415094.
Повний текст джерелаRussell, Clare. "Immunopotentiation of malaria vaccines." Thesis, University of Edinburgh, 2004. http://hdl.handle.net/1842/12892.
Повний текст джерелаHartgroves, Lorian Cedar Safir. "Strategies for influenza vaccines." Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/5558.
Повний текст джерелаUmaimainthan, Palendira. "Improving vaccines against tuberculosis." Thesis, The University of Sydney, 2003. https://hdl.handle.net/2123/27934.
Повний текст джерелаHone, David. "Construction of Salmonella vaccines /." Title page, contents and abstract only, 1988. http://web4.library.adelaide.edu.au/theses/09PH/09phh7721.pdf.
Повний текст джерелаIshizuka, Andrew Scott. "Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:521c5ef4-7d77-456f-910e-f1f207c80b8d.
Повний текст джерелаMcIntyre, Peter. "Measuring the public health impact of vaccines: disease burden, vaccine coverage, safety and effectiveness." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/26251.
Повний текст джерелаHaile, Melles. "Studies on new tuberculosis vaccine candidates in animal models /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-327-2/.
Повний текст джерелаTarcha, Eric J. "Application of Immunoproteomics and Bioinformatics to coccidioidomycosis Vaccinology." University of Toledo Health Science Campus / OhioLINK, 2006. http://rave.ohiolink.edu/etdc/view?acc_num=mco1154441973.
Повний текст джерелаLicata, Matthew J. "The efficacy of combined infectious bronchitis/Newcastle disease vaccines." Access to citation, abstract and download form provided by ProQuest Information and Learning Company; downloadable PDF file, 112 p, 2007. http://proquest.umi.com/pqdlink?did=1253510101&Fmt=7&clientId=79356&RQT=309&VName=PQD.
Повний текст джерелаParker, Fatima Bibi. "Willingness to participate (WTP) in a future HIV vaccine trial in a high risk sample : perceived barriers and facilitators to participation." Thesis, Link to the online version, 2006. http://hdl.handle.net/10019/1151.
Повний текст джерелаLang, Rainer. "Virus-Like particle based vaccines." Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-150810.
Повний текст джерелаBerglund, Peter. "Alphavirus vectors as recombinant vaccines /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2657-3.
Повний текст джерелаTontini, Marta. "Characterization of carbohydrate based vaccines." Phd thesis, Université de Cergy Pontoise, 2012. http://tel.archives-ouvertes.fr/tel-00825838.
Повний текст джерелаSheu, Eric G. "Immunology of T cell vaccines." Thesis, University of Oxford, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.288552.
Повний текст джерелаJenner, Dominic Charles. "Sub-Unit Vaccines for Brucella." Thesis, Open University, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504266.
Повний текст джерелаXu, Damo. "Experimental vaccines against #Leishmania major'." Thesis, King's College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.362657.
Повний текст джерелаChen, Caleb Gonshen. "DNA-based vaccines against cancer." Thesis, University of Southampton, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405968.
Повний текст джерелаLongley, Rhea Jessica. "Liver-stage vaccines for malaria." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:b5c9821c-db32-4b66-a315-02541e62f566.
Повний текст джерелаKayaga, Justina. "Allogenic tumour vaccines for melanoma." Thesis, St George's, University of London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.394404.
Повний текст джерелаLi, Yihang Kaltenboeck Bernhard. "Therapeutic vaccines against chlamydial diseases." Auburn, Ala., 2008. http://hdl.handle.net/10415/1417.
Повний текст джерелаPalladini, Arianna <1978>. "Preclinical development of cancer vaccines." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2009. http://amsdottorato.unibo.it/2035/1/Palladini_Arianna_tesi.pdf.
Повний текст джерелаPalladini, Arianna <1978>. "Preclinical development of cancer vaccines." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2009. http://amsdottorato.unibo.it/2035/.
Повний текст джерелаLi, Tsz-wai, and 李梓維. "Efficacy of combined influenza and 23-valent pneumococcal polysaccharide vaccines in chronic smokers." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/202310.
Повний текст джерелаpublished_or_final_version
Microbiology
Master
Master of Medical Sciences
Zhou, Jingying, and 周京颖. "Efficacy and mechanism of PD1-based DNA vaccines in enhancing HIV-1 Gag-specific immunity." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hub.hku.hk/bib/B50662338.
Повний текст джерелаpublished_or_final_version
Microbiology
Doctoral
Doctor of Philosophy
Yang, Zheng, and 楊爭. "Identification of non-HIV-derived (poly)peptides as primary immunogens for HIV-1 vaccine development and localization of two dominant ADCC epitopes on hemagglutinin antigen of pandemic H1N1 influenza virus." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/208007.
Повний текст джерелаpublished_or_final_version
Microbiology
Doctoral
Doctor of Philosophy
Cassan, Simone de. "Toward improved blood-stage malaria vaccines : characterising the underlying immunogenicity of vaccine adjuvants and vectors." Thesis, University of Oxford, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.560918.
Повний текст джерелаDe, Cassan Simone. "Towards improved blood-stage malaria vaccines : characterising the underlying immunogenicity of vaccine adjuvants and vectors." Thesis, University of Oxford, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711629.
Повний текст джерелаBOEHNER, CONSTANCE WILLIAMS. "FACTORS AFFECTING STD VACCINE ACCEPTANCE IN COLLEGE STUDENTS." University of Cincinnati / OhioLINK, 2002. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1014411621.
Повний текст джерелаMarsay, Leanne. "Evaluation of immune correlates to TB vaccines." Thesis, University of Oxford, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.572645.
Повний текст джерелаIslam, Amina Mahmood. "A qualitative study of women's attitudes towards the introduction of the HPV vaccination in Singapore." Thesis, Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41710034.
Повний текст джерелаOkay, Sezer. "Development Of Recombinant Vaccines Composed Of Plpe And Omph From Pasteurella Multocida A:3." Phd thesis, METU, 2011. http://etd.lib.metu.edu.tr/upload/12613980/index.pdf.
Повний текст джерелаtiters. Protective capacities of the vaccines were also evaluated via challenge of mice with 10 LD50 of P. multocida A:3. DNA vaccines induced immune responses, but did not provide protection. All protein vaccine formulations increased antibody levels and CpG containing formulations enhanced serum IFN-&gamma
titers. 100 µ
g of PlpEC-OmpH protein adsorbed on alum adjuvant conferred 40% protection while no protection was obtained with PlpEN-OmpH. Next, the effects of CpG, or its alum and oil based combinations as adjuvants were investigated on PlpEC-OmpH mediated protection. The vaccine formulation composed of PlpEC-OmpH and oil based-CpG adjuvant conferred 100% protection. Finally, the mice were vaccinated with recombinant OmpH, PlpEC and PlpE formulated with oil based-CpG adjuvant. OmpH, PlpEC and PlpE formulations provided 50%, 60% and 100% protection, respectively. These findings implicated that recombinant PlpE and PlpEC-OmpH fusion proteins when formulated with oil based-CpG adjuvant are potent acellular vaccine formulation candidates against shipping fever.
Boros, Christina Ann. "Factors affecting the immunogenicity and protective efficacy of routine childhood immunisations." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phb736.pdf.
Повний текст джерелаWurzenberger, Cornelia. "Dendritic cell vaccines in tumor immunotherapy." Diss., lmu, 2009. http://nbn-resolving.de/urn:nbn:de:bvb:19-95530.
Повний текст джерелаBrown, Nathan Edward Charles. "Vaccines for Infection Salmon Anemia Virus." Fogler Library, University of Maine, 2003. http://www.library.umaine.edu/theses/pdf/BrownNEC2003.pdf.
Повний текст джерела